TNF and endothelial dysfunction: ADMA, a strong endogenous inhibitor of nitric oxide synthase, induces endothelial dysfunction via various mechanisms, including increased TNF-α production, heightened oxidative stress, and decreased nitric oxide production by inhibiting nitric oxide synthase, all of which can accelerate atherosclerosis [85].